Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

(2016) Anja Hviid Simonsen et al.   Biomarkers in Medicine

Amyloid PET Imaging in Lewy Body Disorders

(2015) Paul Donaghy et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lewy body dementias

(2015) Zuzana Walker et al.   LANCET

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies

(2015) Stephen N. Gomperts et al.   Neurodegenerative Diseases

The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

(2014) Flora H. Duits et al.   Alzheimers & Dementia

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

(2014) David R. Howlett et al.   BRAIN PATHOLOGY

Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies

(2014) Stephen N. Gomperts   Current Neurology and Neuroscience Reports

Conversion between Mini-Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 scores in Parkinson's disease

(2014) Inger van Steenoven et al.   MOVEMENT DISORDERS

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

Concomitant pathologies among a spectrum of parkinsonian disorders

(2014) Brittany N. Dugger et al.   PARKINSONISM & RELATED DISORDERS

Biomarkers in biological fluids for dementia with Lewy bodies

(2014) Sebastian Schade et al.   Alzheimers Research & Therapy

APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease

(2014) Ignacio F. Mata et al.   JAMA Neurology

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies

(2012) J. A. Schneider et al.   BRAIN

Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies

(2012) Hans Brunnström et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Brain amyloid and cognition in Lewy body diseases

(2012) Stephen N. Gomperts et al.   MOVEMENT DISORDERS

Neuropathology underlying clinical variability in patients with synucleinopathies

(2011) Glenda M. Halliday et al.   ACTA NEUROPATHOLOGICA

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Pathological roles of α-synuclein in neurological disorders

(2011) Kostas Vekrellis et al.   LANCET NEUROLOGY

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

(2011) N. S. M. Schoonenboom et al.   NEUROLOGY

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia

(2010) M. Andersson et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Synergistic Interactions between A , Tau, and  -Synuclein: Acceleration of Neuropathology and Cognitive Decline

(2010) L. K. Clinton et al.   JOURNAL OF NEUROSCIENCE

Amyloid imaging of Lewy body-associated disorders

(2010) Erin R. Foster et al.   MOVEMENT DISORDERS

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease

(2009) C. H. Williams-Gray et al.   JOURNAL OF NEUROLOGY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

(2008) Kurt A. Jellinger et al.   ACTA NEUROPATHOLOGICA

Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

(2008) Lucilla Parnetti et al.   BIOLOGICAL PSYCHIATRY